Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

[Pulmonary fibrosis and endovesical mitomycin C].

Janeiro Pais JM, Casas Agudo VP, López Garcia D, González Dacal J, Lamas Meilán C, González Martín M.

Actas Urol Esp. 2009 Jul-Aug;33(7):822-5. Spanish.

PMID:
19757670
2.

Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.

Racioppi M, Porreca A, Foschi N, Delicato G, Destito A, D'Addessi A.

Urol Int. 2005;75(4):373-5.

PMID:
16327311
3.

Intravesical mitomycin-C-induced interstitial pneumonia.

Wada H, Nakano Y, Yamada H, Saiga T, Yamanaka A, Sakai N.

Respiration. 2010;80(3):256-9. doi: 10.1159/000280383. Epub 2010 Jan 30.

4.

[Lung sarcoidosis following instillation of mitomycin C in the urinary bladder].

Cuervo Pinna MA, Cuervo Pinna C, Macías Castillo S, Bureo Dacal JC, Espada Alonso MJ, Pimentel Leo J.

An Med Interna. 2001 Dec;18(12):641-3. Spanish.

PMID:
11852501
5.

Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.

Okumura A, Oishi N, Kaji K, Imamura T, Fuse H.

J Dermatol. 2009 Jul;36(7):419-22. doi: 10.1111/j.1346-8138.2009.00668.x.

PMID:
19583691
6.

Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer.

Mostafid AH, Rajkumar RG, Stewart AB, Singh R.

BJU Int. 2006 Mar;97(3):509-12.

7.

Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.

Kalsi J, Harland SJ, Feneley MR.

Expert Opin Drug Deliv. 2008 Jan;5(1):137-45. Review.

PMID:
18095933
8.

Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.

Shapiro O, Jones K, Wang C, Landas S, Haas GP.

Can J Urol. 2006 Dec;13(6):3317-20. Review.

PMID:
17187694
9.

Intravesical mitomycin C-induced generalized pustular folliculitis.

Andreu-Barasoain M, Gómez de la Fuente E, Pinedo F, Nuño A, López-Estebaranz JL.

J Am Acad Dermatol. 2012 Oct;67(4):e142-3. doi: 10.1016/j.jaad.2011.11.932. No abstract available.

PMID:
22980268
10.

[Intravesical instillation in the treatment of superficial tumors of the bladder].

Chopin DK.

Prog Urol. 1998 Apr;8(2):268-73. Review. French.

PMID:
9615941
11.

[Pulmonary fibrosis following instillation of mitomycin C in the urinary bladder].

Neubauer H, Blech M, Wilhelms E, Crieé CP, Neuhaus KL, Truss F.

Urologe A. 1987 Jan;26(1):41-3. German.

PMID:
3107190
12.

Allergic contact sensitization from intravesical mitomycin C, without dermatitis.

Fidalgo A, Lobo L.

Dermatitis. 2004 Sep;15(3):161-2. No abstract available.

PMID:
15724354
13.

Intravesical mitomycin C for superficial transitional cell carcinoma.

Bolenz C, Cao Y, Arancibia MF, Trojan L, Alken P, Michel MS.

Expert Rev Anticancer Ther. 2006 Aug;6(8):1273-82. Review.

PMID:
16925493
14.

Perivesical inflammation after early mitomycin C instillation.

Cliff AM, Romaniuk CS, Parr NJ.

BJU Int. 2000 Mar;85(4):556-7. No abstract available.

15.
16.

Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer.

Katz G, Hackett RL, Wajsman Z.

Urology. 1996 Jun;47(6):928-9.

PMID:
8677595
17.

Bilateral ureteric strictures after intravesical mitomycin C.

Wass AR, Lawson TR, Urwin GH.

Br J Urol. 1993 Nov;72(5 Pt 1):661-2. No abstract available.

PMID:
10071561
18.
19.

Type III and type IV hypersensitivity reactions due to mitomycin C.

Kunkeler L, Nieboer C, Bruynzeel DP.

Contact Dermatitis. 2000 Feb;42(2):74-6.

PMID:
10703627
20.

[Bladder necrosis after an immediate post-operative mitomycin C instillation].

Branchereau J, Luyckx F, Hitier M, Karam G, Bouchot O, Rigaud J.

Prog Urol. 2011 Feb;21(2):151-3. doi: 10.1016/j.purol.2010.02.008. Epub 2010 May 4. French.

PMID:
21296285

Supplemental Content

Support Center